GBS Inc. changes name to Intelligent Bio Solutions; appoints Harry Simeonidis as CEO

INTELLIGENT BIO SOLUTIONS INC.

Company name changed from GBS Inc. to Intelligent Bio Solutions Inc.; effective Oct 26, 2022.
Nasdaq ticker changes from GBS to INBS effective Oct 27, 2022.
Harry Simeonidis appointed President and CEO, succeeding Steven Boyages who remains Chairman.
David Jenkins and Jason Isenberg appointed to Board of Directors.

item 5.02 item 5.03 item 7.01 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Steven Boyages

Interim Chief Executive Officer

INBS · INTELLIGENT BIO SOLUTIONS INC.

Effective: 2022-10-26
Successor: Harry Simeonidis
Filed: October 27, 2022, 7:59 PM ET

Dr. Steven Boyages, who is stepping down as the Company’s Interim Chief Executive Officer.

Appointed

Harry Simeonidis

President and Chief Executive Officer

INBS · INTELLIGENT BIO SOLUTIONS INC.

Effective: 2022-10-26
Successor: Steven Boyages
Filed: October 27, 2022, 7:59 PM ET

elected Harry Simeonidis, who currently serves as the Company’s President Asia Pacific, Sales and Marketing, as the Company’s President and Chief Executive Officer, effective as of October 26, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Steven Boyages changed role as Interim Chief Executive Officer at INTELLIGENT BIO SOLUTIONS INC..

Action: stepping down
Role: Interim Chief Executive Officer

Exact text from the filing

Dr. Steven Boyages, who is stepping down as the Company’s Interim Chief Executive Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Harry Simeonidis was elected as President and Chief Executive Officer at INTELLIGENT BIO SOLUTIONS INC..

Action: elected
Role: President and Chief Executive Officer

Exact text from the filing

elected Harry Simeonidis, who currently serves as the Company’s President Asia Pacific, Sales and Marketing, as the Company’s President and Chief Executive Officer, effective as of October 26, 2022.

View on SEC.gov

INTELLIGENT BIO SOLUTIONS INC. filing history →

Source: SEC EDGAR

accession 0001493152-22-029686

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.